PHASE 1 SUMMARY OF ANF-RHO, A NOVEL PEG-MODIFIED FILGRASTIM INVESTIGATIONAL PRODUCT WITH SUPERIOR PK/PD PROPERTIES THAT MAY PROVIDE IMPROVED CONTROL OF NEUTROPENIA DURING DOSE-DENSE CHEMOTHERAPY
HAEMATOLOGICA(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要